This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Acevedo, L. G. Articles by Farnham, P. J. Search for Related Content PubMed PubMed Citation Articles by Acevedo, L. G. Articles by Farnham, P. J.

Analysis of the Mechanisms Mediating Tumor-Specific Changes in Gene Expression in Human Liver Tumors

¹ Department of Pharmacology and the Genome Center, University of California-Davis, Davis, California and ² Roche NimbleGen, Madison, Wisconsin

Requests for reprints: Peggy J. Farnham, Genome and Biomedical Sciences Facility, University of California-Davis, One Shields Avenue, Davis, CA 95616. Phone: 530-754-4988; Fax: 530-754-9658; E-mail: pjfarnham{at}ucdavis.edu.

Key Words: liver tumors • RNA profiling • ChIP-chip • comparative genomic hybridization

There is widespread interest in efficient characterization of differences between tumor and normal samples. Here, we show an effective methodology for genome-scale characterization of tumors. Using matched normal and tumor samples from liver cancer patients, as well as non–cancer-related normal liver tissue, we first determined changes in gene expression as monitored on RNA expression arrays. We identified several hundred mRNAs that were consistently changed in the tumor samples. To characterize the mechanisms responsible for creation of the tumor-specific transcriptome, we performed chromatin immunoprecipitation on microarray experiments to assay binding of RNA polymerase II, H3me3K27, and H3me3K9 and DNA methylation in 25,000 promoter regions. These experiments identified changes in active and silenced regions of the genome in the tumor cells. Finally, we used a "virtual comparative genomic hybridization" method to identify copy number alterations in the tumor samples. Through comparison of RNA polymerase II binding, chromatin structure, DNA methylation, and copy number changes, we suggest that the major contributor to creation of the liver tumor transcriptome was changes in gene copy number. [Cancer Res 2008;68(8):2641–51]

This article has been cited by other articles:

				A. Rabinovich, V. X. Jin, R. Rabinovich, X. Xu, and P. J. Farnham E2F in vivo binding specificity: Comparison of consensus versus nonconsensus binding sites Genome Res., November 1, 2008; 18(11): 1763 - 1777. [Abstract] [Full Text] [PDF]